Eye Care - Eastern Europe

Eastern Europe

Highlights

Revenue in the Eye Care market amounts to US$180.50m in 2024. The market is expected to grow annually by 2.50% (CAGR 2024-2029).
In global comparison, most revenue is generated United States (US$1bn in 2024).
In relation to total population figures, per person revenues of US$0.76 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Eye Care market in Eastern Europe is experiencing steady growth and development due to several factors. Customer preferences in Eastern Europe are shifting towards a greater focus on eye health and the importance of regular eye care.

With an aging population and increasing awareness about the importance of maintaining good eye health, consumers are seeking out products and services that can help them address and prevent eye-related issues. This includes a growing demand for prescription eyewear, contact lenses, and eye care supplements. Trends in the market indicate a rise in the number of people seeking professional eye care services, such as regular eye exams and consultations with ophthalmologists.

This can be attributed to increased disposable income and improved access to healthcare services in the region. As a result, there is a growing demand for optometrists and ophthalmologists, as well as a need for advanced diagnostic and treatment technologies. Local special circumstances in Eastern Europe also contribute to the development of the Eye Care market.

The region has a high prevalence of certain eye conditions, such as myopia and age-related macular degeneration, which drive the demand for corrective eyewear and specialized treatments. Additionally, the presence of a large number of optical retail chains and online eyewear platforms provides consumers with a wide range of options to choose from, further fueling market growth. Underlying macroeconomic factors, such as increasing urbanization and rising disposable incomes, play a significant role in the growth of the Eye Care market in Eastern Europe.

As more people move to urban areas and experience higher levels of income, they are willing to spend more on eye care products and services. This includes investing in high-quality eyewear, opting for advanced treatment options, and purchasing eye care supplements. In conclusion, the Eye Care market in Eastern Europe is developing due to shifting customer preferences towards eye health, increasing demand for professional eye care services, local special circumstances, and underlying macroeconomic factors.

As the region continues to prioritize eye health and improve access to healthcare services, the market is expected to witness further growth and innovation in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.